Treatment of lupus nephritis and primary glomerulonephritis with enteric-coated mycophenolate sodium

• Main Authors: Kitiyakara C., Ophascharoensuk V., Changsirikulchai S., Ingsathit A., Tankee P., Sangpanich A., Sumethkul V.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-38949161453&partnerID=40&md5=f1e78ea4da784d8a4d3e8f6dc9acdf42; http://cmuir.cmu.ac.th/handle/6653943832/2480

Aims: Mycophenolate mofetil is an effective therapy for lupus nephritis (LN) and other glomerulonephritis (GN). However, gastrointestinal (GI) complications can limit its use. Enteric-coated mycophenolate sodium (EC-MPS) has been designed to reduce GI adverse events, but it has not been fully invest...